In This Section

Ray Fuller Lecture and Symposium: State-of-the-Art on Regenerative Pharmacology: The Future is Now

Sunday April 22, 2018

9:30 am - 12:00 pm

Room 17A
Sponsored by the Division for Translational and Clinical Pharmacology (TCP)
Co-sponsored by the Division for Cancer Pharmacology (DCP)
Co-sponsored by the Division for Drug Discovery and Development (DDD)
Co-sponsored by the Division for Pharmacology Education (DPE)

Chair :

Kacey Marra
University of Pittsburgh

George Christ
University of Virginia


Regenerative medicine is a rapidly evolving multidisciplinary, translational research enterprise whose explicit purpose is to advance technologies for the repair and replacement of damaged cells, tissues, and organs. Scientific progress in the field has been steady and expectations for increased clinical applications continue to rise. Regenerative pharmacology seeks to cure disease through the application of the pharmacological sciences to new technology development for restoration of tissue/organ function. Recent developments in materials science, chemical engineering and stem cell biology are poised to push the frontiers of regenerative pharmacology toward novel and more efficacious therapeutics for a variety of unmet medical needs.

Ray Fuller Lecture: Regenerative Pharmacology for Muscle Repair
George Christ - University of Virginia

Keratin Biomaterials as an Implantable Device, As Well As a Platform for Cell and Drug Delivery for Tissue Repair and Regeneration
Luke Burnett - Keranetics LLC

Stem Cell Engraftment through Enhanced Vascular Integration with Functionalized Biomaterials
Kevin Healy - University of California, Berkeley 

Therapeutic Angiogenic Materials for Tissue Repair and Regeneration
Tatiana Segura - University of California, Los Angeles